[ET Net News Agency, 22 August 2019] YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
(01558) said its profit and total comprehensive income attributable to equity shareholders
of the company was RMB968.42 million for the six months ended 30 June 2019, a year-on-year
increase of 52.62%. The earnings per share were RMB2.15. An interim dividend of RMB1 will
be distributed.
The revenue was RMB3.07 billion, a year-on-year increase of 107.18%. The gross profit
was RMB2.62 billion, a year-on-year increase of 110.77%. (RC)